Targeted Delivery of Small and Macromolecular Drugs: 1st Edition (Paperback) book cover

Targeted Delivery of Small and Macromolecular Drugs

1st Edition

Edited by Ajit S. Narang, Ram I. Mahato

CRC Press

630 pages | 185 B/W Illus.

Purchasing Options:$ = USD
Paperback: 9781138114517
pub: 2017-07-26
Hardback: 9781420087727
pub: 2010-05-12
eBook (VitalSource) : 9780429144509
pub: 2010-05-12
from $110.00

FREE Standard Shipping!


Site-specific drug delivery and targeting attracts much research interest from both academia and industry, but because of the many challenges faced in the development of these systems, only a handful of targeted therapies have successfully made it into clinical practice.

Focusing on the delivery technologies that utilize both systemic and local routes of administration, Targeted Delivery of Small and Macromolecular Drugs brings together field experts who summarize current progress and discuss novel ideas currently being explored to overcome these challenges.

The contributors discuss the most promising strategies for drug targeting and also examine targeted drug delivery platforms and technologies at various stages of clinical and preclinical development, including:

    • Active targeting
    • Nucleic acid delivery and targeting
    • Intracellular/organelle-specific strategies
    • Prodrug strategies
    • Organ or tissue-specific drug delivery
    • Drug-polymer conjugates and micelles
    • Stimuli-responsive systems

The book demonstrates why targeted delivery is one of the most exciting contributions pharmaceutical sciences can make to drug therapy.

Table of Contents

Therapeutic Potential of Targeted Drug Delivery

Ajit S. Narang and Ram I. Mahato


Antibody Therapies for Liver Malignancy and Transplantation

John M. Luk and Kwong-Fai Wong

Transferrin Receptor–Mediated Transcytosis in Intestinal Epithelial Cells for Gastrointestinal Absorption of Protein Drugs

Nurmamet Amet, Xiaoying Chen, Hsin-Fang Lee, Jennica Zaro, and Wei-Chiang Shen

Ionizing Radiation for Tumor-Targeted Drug Delivery

Roberto Diaz, Li Zhou, and Dennis E. Hallahan


Recent Advances in Gene Expression and Delivery Systems

Ravikiran Panakanti and Ram I. Mahato

Cellular Barriers for Nucleic Acid Delivery and Targeting

Arto Urtti

Targeted Delivery Systems of Nonviral Nucleic Acid–Based Therapeutics

Ga Yong Shim, Eun-Joong Kim, Rae Sung Chang, Han Young Lee, and Yu-Kyoung Oh

Delivery and Targeting of Oligonucleotides and siRNA

Ningning Yang and Ram I. Mahato

Liposomes for Nonviral Gene Delivery

Jiasheng Tu, Yan Shen, Hui Pang, and Yubing Yu


Delivering the Bullet to the Right Intracellular Target: A Cellular Perspective on Drug Delivery

Maria Teresa Tarragó-Trani and Brian Storrie

Mitochondria-Targeted Drug Delivery

Volkmar Weissig and Gerard G. M. D’Souza


Site-Specific Prodrug Activation Strategies for Targeted Drug Action

Mark D. Erion

Enzyme-Activated Prodrug Strategies for Targeted Drug Action

Jarkko Rautio, Krista Laine, Lanyan Fang, Bing Han, Kristiina Huttunen, and Duxin Sun


Targeting Colon and Kidney: Pathophysiological Determinants of Design Strategy

Ajit S. Narang and Ram I. Mahato

Principles and Practice of Pulmonary Drug Delivery

Vivek Gupta, Chandan Thomas, and Fakhrul Ahsan

Recent Advances in Ocular Drug Delivery: Role of Transporters, Receptors, and Nanocarriers

Gyan P. Mishra, Ripal Gaudana, Viral M. Tamboli, and Ashim K. Mitra


Injectable Polymers for Regional Drug Delivery

Rajendra P. Pawar, Niteen R. Shinde, Narsinha M. Andurkar, Satish A. Dake, and Abraham J. Domb

Polymer–Drug Conjugates

Lucienne Juillerat-Jeanneret and Feride Cengelli

Polymer Micelles for Drug Delivery

Sungwon Kim and Kinam Park


Multifunctional Stimuli–Responsive Nanoparticles for Targeted Delivery of Small and Macromolecular Therapeutics

Srinivas Ganta, Arun Iyer, and Mansoor Amiji

Physiological Stress Responsive Gene Regulation Systems for Tissue Targeting

Hyun Ah Kim and Minhyung Lee

About the Editors

Ajit S. Narang works for the Bristol-Myers Squibb, Co. in New Brunswick, New Jersey, in the biopharmaceutical aspects of drug delivery. He has more than eight years of experience in the pharmaceutical industry in the development of oral dosage forms and drug delivery platforms. In addition to the Bristol-Myers Squibb, Co., he has worked for Ranbaxy Research Labs (currently a subsidiary of Daiichi Sankyo, Japan) in Gurgaon, India, and Morton Grove Pharmaceuticals (currently a subsidiary of Wockhardt USA LLC, Parsippany, New Jersey) in Vernon Hills, Illinois. He has more than 35 publications and three pending patent applications, and has contributed to the development of several marketed drug products.

Ram I. Mahato is a full-time professor in the Department of Pharmaceutical Sciences at the University of Health Science Center, Memphis, Tennessee. He was a research assistant professor at the University of Utah, Salt Lake City; a senior scientist at GeneMedicine, Inc., The Woodland, Texas; and a postdoctoral fellow at the University of Southern California in Los Angeles, Washington University in St. Louis, and Kyoto University, Japan. He is an author or coauthor of 79 peer-reviewed articles and book chapters, and has edited/written three books. He is also a special features editor of Pharmaceutical Research and serves on the editorial boards of the Journal of Drug Targeting, Expert Opinion on Drug Delivery, and Transplantation and Risk Management. His research includes delivery and targeting of small molecules, oligonucleotides, siRNA, and genes.

Subject Categories

BISAC Subject Codes/Headings:
MEDICAL / Pharmacology
MEDICAL / Pharmacy